994
Views
0
CrossRef citations to date
0
Altmetric
Cognition

Development, reliability, validity, and acceptability of the remote administration of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS)

, , ORCID Icon, , , , , , , & show all
Pages 96-103 | Received 03 Jul 2023, Accepted 23 Oct 2023, Published online: 11 Nov 2023

References

  • NICE. Motor neurone disease: assessment and management 2016. Available from: https://www.nice.org.uk/guidance/ng42.
  • Beswick E, Forbes D, Hassan Z, Wong C, Newton J, Carson A, et al. A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis. J Neurol. 2022;269:411–26.
  • Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12:368–80.
  • Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology 2018;91:e1370–e1380.
  • Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
  • Strong MJ, Abrahams S, Goldstein LH, Woolley S, McLaughlin P, Snowden J, et al. Amyotrophic lateral sclerosis – frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153–74.
  • Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456–77.
  • Pinto-Grau M, Burke T, Lonergan K, McHugh C, Mays I, Madden C, et al. Screening for cognitive dysfunction in ALS: validation of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted normative data. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:99–106.
  • Lulé D, Burkhardt C, Abdulla S, Böhm S, Kollewe K, Uttner I, et al. The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:16–23.
  • Niven E, Newton J, Foley J, Colville S, Swingler R, Chandran S, et al. Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): a cognitive tool for motor disorders. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:172–9.
  • Fox-Fuller JT, Rizer S, Andersen SL, Sunderaraman P. Survey findings about the experiences, challenges, and practical advice/solutions regarding teleneuropsychological assessment in adults. Arch Clin Neuropsychol. 2022;37:274–91.
  • Brearly TW, Shura RD, Martindale SL, Lazowski RA, Luxton DD, Shenal BV, et al. Neuropsychological test administration by videoconference: a systematic review and meta-analysis. Neuropsychol Rev. 2017;27:174–86.
  • Requena-Komuro M-C, Jiang J, Dobson L, Benhamou E, Russell L, Bond RL, et al. Remote versus face-to-face neuropsychological testing for dementia research: a comparative study in people with Alzheimer’s disease, frontotemporal dementia and healthy older individuals. BMJ Open. 2022;12:e064576.
  • Yoshida K, Yamaoka Y, Eguchi Y, Sato D, Iiboshi K, Kishimoto M, et al. Remote neuropsychological assessment of elderly Japanese population using the Alzheimer’s Disease Assessment Scale: a validation study. J Telemed Telecare. 2020;26:482–7.
  • Crockford CJ, Kleynhans M, Wilton E, Radakovic R, Newton J, Niven EH, et al. ECAS ABC: alternate forms of the Edinburgh cognitive and behavioural ALS screen. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:57–64.
  • Leighton D, Newton J, Colville S, Bethell A, Craig G, Cunningham L, et al. Clinical audit research and evaluation of motor neuron disease (CARE-MND): a national electronic platform for prospective, longitudinal monitoring of MND in Scotland. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:242–50.
  • Crockford C, Newton J, Lonergan K, Madden C, Mays I, O'Sullivan M, et al. Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:65–73.
  • Geronimo A, Wright C, Morris A, Walsh S, Snyder B, Simmons Z. Incorporation of telehealth into a multidisciplinary ALS Clinic: feasibility and acceptability. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:555–61.
  • Sandstedt P, Littorin S, Johansson S, Gottberg K, Ytterberg C, Kierkegaard M. Disability and contextual factors in patients with amyotrophic lateral sclerosis-a three-year observational study. J Neuromuscul Dis. 2018;5:439–49.
  • Foley JA, Niven EH, Paget A, Bhatia KP, Farmer SF, Jarman PR, et al. Sensitivity and specificity of the ECAS in Parkinson’s disease and progressive supranuclear palsy. Parkinson’s Disease. 2018;2018:1–8.
  • De Icaza Valenzuela MM, Bak TH, Thompson HE, Colville S, Pal S, Abrahams S. Validation of the Edinburgh cognitive and behavioural ALS screen (ECAS) in behavioural variant frontotemporal dementia and Alzheimer’s disease. Int J Geriatr Psychiatry. 2021;36:1576–87.
  • Carelli L, Solca F, Migliore S, Torre S, Brugnera A, Mancini F, et al. Compensating for verbal-motor deficits in neuropsychological assessment in movement disorders: sensitivity and specificity of the ECAS in Parkinson’s and Huntington’s diseases. Neurol Sci. 2021;42:4997–5006.
  • De Icaza Valenzuela MM, Bak TH, Pal S, Abrahams S. The Edinburgh Cognitive and Behavioral ALS screen: relationship to age, education, IQ and the Addenbrooke’s Cognitive Examination-III. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:585–90.